SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Access with Evidence Development Schemes · Study

ArticleShelves

ArticleAccess with Evidence Development Schemes

Christopher J. McCabe2010

Article2010

Access with Evidence Development Schemes

Christopher J. McCabe · Tania Stafinski · Richard P. Edlin · Devidas Menon

87 citations·0/0 files stored·PharmacoEconomics

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Policy and Management Health Systems, Economic Evaluations, Quality of Life

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 87 citations exist upstream.

References

2008Exploring Uncertainty in Cost-Effectiveness Analysis 2003Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosisCommentary: Evaluating disease modifying treatments in multiple sclerosis 2010Funding the Unfundable

Cited by

2012USING HEALTH TECHNOLOGY ASSESSMENT TO SUPPORT OPTIMAL USE OF TECHNOLOGIES IN CURRENT PRACTICE: THE CHALLENGE OF “DISINVESTMENT”

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2020Calculating and Interpreting ICERs and Net Benefitarticle · 1 shared reference 2011Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Modelsarticle · 1 shared reference 2018Cost-effectiveness analyses of genetic and genomic diagnostic testsreview · 1 shared reference 2013Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countriesarticle · 1 shared reference 2011Cost-effectiveness of disease-modifying therapy for multiple sclerosisarticle · 1 shared reference 2020Challenges in synthesising cost-effectiveness estimatesarticle · 1 shared reference

Details

Year2010

Typearticle

Published2010-01-20

VenuePharmacoEconomics

ISSN-L1170-7690

Languageen

Citations87

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.2165/11530850-000000000-00000

openalex_workW2082957553

Links

Imported from OpenAlex (CC0) — nothing here is generated.